SUBSCRIBE
SUBSCRIBE
News   Drug Development

FDA Issues Merck & Co., Inc. Warning for High Doses of Zocor

March 22, 2010 | 
1 min read
Reuters -- Patients on the highest approved dose of the cholesterol-lowering drug Zocor may be at increased risk of muscle injury, U.S. regulators warned on Friday.
Clinical research Postmarket research Regulatory
Merck & Co. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Sanofi's Distribution Center in Quebec, Canada
Immunology and inflammation
Sanofi’s Anti-OX40 Blocker Falls ‘Well Below Expectations’ in Phase III Eczema Study
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
halftone magazine style banner, dislike, negative rating, hand thumbs down
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
 · 
4 min read
 · 
Annalee Armstrong
IN PARTNERSHIP WITH TACONIC BIOSCIENCES
The ‘Research Safety Net’ Saving Scientists from Funding Crisis
September 4, 2025
 · 
1 min read
 · 
Lori Ellis
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Regulatory
‘All Wrapper, No Gift’: FDA Releases New Rare Disease Approval Framework
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac